MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Nectar Lifesciences
Nectar Lifesciences
BSE: 532649|NSE: NECLIFE|ISIN: INE023H01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 28, 17:00
20.45
0.35 (1.74%)
VOLUME 11,651
LIVE
NSE
May 28, 17:00
20.50
0.35 (1.74%)
VOLUME 17,756
Business News on Nectar Lifesciences
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
To see robust revenue from 2013: Nectar Lifesciences 

2.53 pm | 08 Dec 2011 |  Source: CNBC-TV18

In an interview to CNBC-TV18, DINESH DUA, chief executive officer of Nectar Lifesciences spoke about the approval it has received from European market...

API facility to boost revenue by 5-10%: Nectar Lifesciences 

2.29 pm | 14 Oct 2011 |  Source: CNBC-TV18

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab. Dinesh Dua, chief executi...

Nectar Lifesciences gets European nod for Punjab plant 

12.00 pm | 14 Oct 2011 |  Source: Moneycontrol.com

Nectar Lifesciences has received European approval for its Cephalosporin APIs manufacturing facility at Derabassi in Punjab....

Nectar Lifesciences receives USFDA nod for Dera Bassi plant 

9.12 pm | 08 Sep 2011 |  Source: PTI

Nectar Lifesciences today said it has received approval from the US health regulator for its manufacturing facility at Dera Bassi in Punjab. ...

Nectar Lifesciences manufacturing unit gets US FDA nod 

2.41 pm | 08 Sep 2011 |  Source: Moneycontrol.com

Nectar Lifesciences has received US Food and Drugs Administration (FDA) approval for its Active Pharmaceutical Ingredients (API) manufacturing plant U...

USFDA nod will open up lucrative market for us: Nectar Lifesciences 

4.19 pm | 23 Mar 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Dinesh Dua, CEO of Nectar Lifesciences said, "It’s going to happen at April. As soon as the approval is through we wil...

Nectar Lifesciences targets Rs 1300cr revenues in FY12 

4.43 pm | 04 Mar 2011 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Dinesh Dua, CEO of Nectar Lifesciences said,"We are looking at about close to Rs 1,300 plus crore topline for the next...

1
Quick Links for Nectar Lifesciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.